Page last updated: 2024-09-03

4-benzyl-3-crotonyl-2-oxazolidinone and Breast Cancer

4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beshir, AB; Fenteany, G; Mc Henry, KT; Montesano, R; Tang, HH; Yeung, KC; Zhu, S1

Other Studies

1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and Breast Cancer

ArticleYear
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
    Journal of cellular biochemistry, 2008, Feb-15, Volume: 103, Issue:3

    Topics: Adherens Junctions; Animals; Breast Neoplasms; Cadherins; Cell Movement; Cell-Matrix Junctions; Dogs; Down-Regulation; Epithelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Humans; Integrin beta1; Kidney Neoplasms; Membrane Proteins; Oxazolidinones; Phosphatidylethanolamine Binding Protein; Phosphoproteins; Protein Kinase Inhibitors; raf Kinases; RNA Interference; Tumor Cells, Cultured; Up-Regulation; Wound Healing; Zonula Occludens-1 Protein

2008